Picture of boy being examining by doctor at a tuberculosis sanatorium

Understanding our future through Open Access research about our past...

Strathprints makes available scholarly Open Access content by researchers in the Centre for the Social History of Health & Healthcare (CSHHH), based within the School of Humanities, and considered Scotland's leading centre for the history of health and medicine.

Research at CSHHH explores the modern world since 1800 in locations as diverse as the UK, Asia, Africa, North America, and Europe. Areas of specialism include contraception and sexuality; family health and medical services; occupational health and medicine; disability; the history of psychiatry; conflict and warfare; and, drugs, pharmaceuticals and intoxicants.

Explore the Open Access research of the Centre for the Social History of Health and Healthcare. Or explore all of Strathclyde's Open Access research...

Image: Heart of England NHS Foundation Trust. Wellcome Collection - CC-BY.

The breath test - A call for more regional use

Heaney, A. and Kalin, R.M. and Collins, J.S.A. and Watson, R.G.P. and McFarland, R.J. (1997) The breath test - A call for more regional use. European Journal of Gastroenterology and Hepatology, 9 (7). pp. 693-696.

Full text not available in this repository. Request a copy from the Strathclyde author

Abstract

Objective: Although the C-13-urea breath test is commonly used for detection of Helicobacter pylori infection and eradication, access to commercial testing centres for analysis may at times limit its use. We have addressed this issue by establishing a regional-based means of analysis as a Hospital-University collaboration. Design/methods: A blind comparison was undertaken of C-13-urea breath test results performed 'in house' by the stable isotope laboratory in Queen's University Belfast and a commercially available C-13-urea breath test. Results: The H. pylori status of the patients (n = 110) agreed for all patients (kappa score = 1). The excess values showed good agreement. The cost of the 'in house' breath test was less than 20 pounds compared with 32.90 pounds for the commercial breath test. Conclusion: Regional access to the C-13-urea breath test could decrease costs, increase availability of testing, improve local health services and economy and increase collaborative research opportunities.